FDA Inspection 601115 — ARCA Biopharma, Inc.

ARCA Biopharma, Inc. — FEI 3007190408

The FDA completed an inspection of ARCA Biopharma, Inc. on Mar 9, 2009 in Westminster, CO. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Mar 9, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Westminster, CO (United States)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
200921 CFR 211.188Prepared for each batch, include complete information
748821 CFR 312.59Records of unused drug disposition
755821 CFR 312.57(c)Record retention requirement